Drugs / EVT 101
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00526968 | Sep → Dec 2007 | — | Evotec Neurosciences GmbH | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01128452 | Jun 2010 → Mar 2011 | major depressive disorder | Janssen Research & Development, LLC | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EVT 101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01128452 ↗ |
| Modality | Small molecule | — CHEMBL3545350 ↗ |
| Route | Oral | “8 mg capsule, single oral dose” NCT00526968 ↗ |